Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in PCOS (PCOvit-D)
NCT03898934Phase 4Completed
- Sponsor
- Tanta University
- Start
- Apr 2019
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in polycystic ovary syndrome (PCOS), infertility and Vitamin D deficiency (VDD) comparing Vitamin D group with Placebo group (2 arms). Primary endpoints: Ovulation rate at 3 months and Pregnancy rate at 3 months. Started Apr 2019; status: completed.
02
Drugs
vitamin d
03
Conditions
polycystic ovary syndrome (PCOS)infertilityVitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03898934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03898934.